Immunometabolic Approaches Mitigating Foreign Body Response and Transcriptome Characterization of the Foreign Body Capsule
Advanced Healthcare Materials · 2025-02 · 14 (5)
DOI: 10.1002/adhm.202400602 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 15.08.2024. Verfasst von Sabrina L Macias und 5 weiteren Autor:innen. Beteiligte Einrichtung: J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, 32611, USA. Hauptthemen laut MEDLINE: Transcriptome, Foreign-Body Reaction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, NIDDK NIH HHS, NIDCR NIH HHS.
Abstract (Originalsprache)
Directing immunometabolism presents new opportunities to modulate key cell types associated with the formation of foreign body response (FBR) capsule. Contrasting approaches directing immunometabolism are investigated to mitigate FBR: a broadly suppressive metabolic inhibitor (MI) cocktail comprised of 2‐deoxyglucose (2‐DG), metformin, and 6‐diazo‐5‐oxo‐l‐norleucine (DON) with daily systemic dosing regimen, and local weekly injection of the more narrowly focused tryptophan catabolizing IDO‐Gal3 fusion protein. Treatments significantly decrease FBR capsule formed around subcutaneously implanted cellulose disks. MI cocktail results in a substantially thinner FBR capsule (40% of control), while weekly local injection of IDO‐Gal3 also results in a thinner FBR capsule (69% of control). RNA‐sequencing capsule transcripts reveal MI cocktail promotes quiescence, with decreased antigen processing and presentation, T helper subset differentiation, and cytokine‐cytokine receptor pathway. IDO‐Gal3 promotes pro‐regenerative, alternatively activated M2‐like macrophages and T helper 2 cells, with increased expression of type 2 response‐associated genes ( Il4 , Il13 , Arg1 , Mrc1 , Chil3 , Gata3 ). IDO‐Gal3 decreases pro‐inflammatory innate sensing pathways, and C‐type lectin receptor, NOD‐like receptor, RIG‐I‐like receptor, and Toll‐like receptor signaling. This work helps define key gene targets and pathways concomitantly regulated in the FBR capsule during immunometabolic modulation compared to control FBR capsule.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, 32611, USA.
- Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.
ORCID-Profile: Benjamin G Keselowsky
Förderung
- National Institute of Allergy and Infectious Diseases
- NIDDK NIH HHS
- NIDCR NIH HHS
- NIAID NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Macias, S. L., Palmer, O., Simonovich, J. A., Clark, R. A., Hudalla, G. A., & Keselowsky, B. G. (2025). Immunometabolic Approaches Mitigating Foreign Body Response and Transcriptome Characterization of the Foreign Body Capsule. Advanced Healthcare Materials, 14(5). https://doi.org/10.1002/adhm.202400602
Vancouver
Macias SL, Palmer O, Simonovich JA, Clark RA, Hudalla GA, Keselowsky BG. Immunometabolic Approaches Mitigating Foreign Body Response and Transcriptome Characterization of the Foreign Body Capsule. Advanced Healthcare Materials. 2025;14(5). doi:10.1002/adhm.202400602
BibTeX
@article{Macias2025,
author = {Macias, Sabrina L and Palmer, Olivia and Simonovich, Jennifer A and Clark, Ryan A and Hudalla, Gregory A and Keselowsky, Benjamin G},
title = {Immunometabolic Approaches Mitigating Foreign Body Response and Transcriptome Characterization of the Foreign Body Capsule},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {5},
doi = {10.1002/adhm.202400602}
}
EUVIMED